News
Oppenheimer Maintains Outperform on Crinetics Pharmaceuticals, Raises Price Target to $55
20 Mar 24
News, Price Target, Analyst Ratings
JMP Securities Maintains Market Outperform on Crinetics Pharmaceuticals, Raises Price Target to $80
20 Mar 24
News, Price Target, Analyst Ratings
JonesTrading Maintains Buy on Crinetics Pharmaceuticals, Raises Price Target to $56
20 Mar 24
News, Price Target, Analyst Ratings
Endocrine Disease-Focused Crinetics Pharmaceuticals Stock Soars On Tuesday - Here's Why
19 Mar 24
Biotech, News, Health Care, Movers, Trading Ideas, General
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
19 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $50 Price Target
19 Mar 24
News, Price Target, Reiteration, Analyst Ratings
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
19 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Market-Moving News for March 19th
19 Mar 24
Movers, Trading Ideas
JMP Securities Reiterates Market Outperform on Crinetics Pharmaceuticals, Maintains $60 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Oppenheimer Reiterates Outperform on Crinetics Pharmaceuticals, Raises Price Target to $54
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $50 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Crinetics Announces Positive Topline Results From Phase 2 Trial Of Paltusotine For The Treatment Of Carcinoid Syndrome; Demonstrated Rapid And Sustained Reductions In Frequency And Severity Of Flushing Episodes And Bowel Movements
12 Mar 24
Biotech, News, General
HC Wainwright & Co. Maintains Buy on Crinetics Pharmaceuticals, Raises Price Target to $50
8 Mar 24
News, Price Target, Analyst Ratings
Citigroup Initiates Coverage On Crinetics Pharmaceuticals with Buy Rating, Announces Price Target of $68
6 Mar 24
News, Price Target, Initiation, Analyst Ratings
Cantor Fitzgerald Maintains Overweight on Crinetics Pharmaceuticals, Raises Price Target to $65
4 Mar 24
News, Price Target, Analyst Ratings
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
1 Mar 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
JMP Securities Maintains Market Outperform on Crinetics Pharmaceuticals, Raises Price Target to $60
29 Feb 24
News, Price Target, Analyst Ratings
Oppenheimer Maintains Outperform on Crinetics Pharmaceuticals, Raises Price Target to $48
29 Feb 24
News, Price Target, Analyst Ratings
The Analyst Verdict: Crinetics Pharmaceuticals In The Eyes Of 6 Experts
29 Feb 24
Analyst Ratings
Crinetics Pharmaceuticals Q4 EPS $(0.90) Misses $(0.86) Estimate
28 Feb 24
Earnings, News
Press releases
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Apr 24
Press Releases
Crinetics' Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
19 Mar 24
Press Releases
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
14 Feb 24
News, Press Releases